-
1 Comment
KDA Group Inc is currently in a long term downtrend where the price is trading 15.4% below its 200 day moving average.
From a valuation standpoint, the stock is 99.9% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 1.0.
KDA Group Inc's total revenue sank by 4.4% to $6M since the same quarter in the previous year.
Its net income has increased by 287.6% to $220K since the same quarter in the previous year.
Finally, its free cash flow grew by 94.4% to $-14K since the same quarter in the previous year.
Based on the above factors, KDA Group Inc gets an overall score of 3/5.
Exchange | V |
---|---|
CurrencyCode | CAD |
ISIN | CA48669F1071 |
Sector | Healthcare |
Industry | Medical Care Facilities |
Market Cap | 45M |
---|---|
PE Ratio | None |
Beta | 1.45 |
Target Price | None |
Dividend Yield | None |
KDA Group Inc., together with its subsidiaries, provides technological solutions to general and specialized health sectors in Canada. It offers Prescripteur KRx, an electronic prescription platform assisting dentists in practice; KRx Cannabinoid, an electronic prescription platform helping doctors in practice for prescribing medical cannabis; Adherize (ADRX), a suite of virtual resources to present and share crucial information for doctors and pharmacists, as well as a patient portal allows easy access to personalized information; and Medherize, a platform for clinical management of patients requiring specialized medication. The company was formerly known as AlliancePharma Inc. and changed its name to KDA Group Inc. in February 2017. KDA Group Inc. is headquartered in Thetford Mines, Canada.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for KDA.V using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025